Sponsored by:

Nuclear Medicine: Page 275

NRG schedules Petten reactor repairs
By AuntMinnie.com staff writers
Dutch radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) will begin repairs to the primary cooling water pipework of its High Flux Reactor on February 19, 2010.
December 14, 2009
Dilon nets FDA nod
By AuntMinnie.com staff writers
Breast-specific gamma imaging developer Dilon Diagnostics has received U.S. Food and Drug Administration 510(k) clearance for its GammaLoc lesion localization system.
December 14, 2009
PET detects Alzheimer's disease likely to progress
By AuntMinnie.com staff writers
Early Alzheimer's disease detected by a compound that binds to brain plaques appears likely to progress into symptomatic Alzheimer's disease with dementia, according to a report in the December issue of Archives of Neurology.
December 14, 2009
Canadian court approves ART bankruptcy
By AuntMinnie.com staff writers
Optical molecular imaging developer ART Advanced Research Technologies has received approval from the Quebec Superior Court for the company's proposal to file for bankruptcy.
December 10, 2009
FDA issues final cGMP rules for PET drugs
By Wayne Forrest
The U.S. Food and Drug Administration on December 10 issued its final rule on current good manufacturing practices (cGMPs) for all PET radiopharmaceuticals, noting that the regulations may have a "significant impact on a substantial number" of small manufacturers.
December 10, 2009
NRG endorses Petten site for reactor
By AuntMinnie.com staff writers
Dutch radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) has expressed its preference for Petten, Netherlands, as the site of its proposed research reactor.
December 7, 2009
Canadian panel promotes new reactor
By AuntMinnie.com staff writers
The Canadian government should build a new nuclear reactor to produce medical isotopes and guarantee an adequate supply for the country, an expert panel has recommended.
December 7, 2009
CMS considers F-18 NaF PET coverage
By AuntMinnie.com staff writers
The U.S. Centers for Medicare and Medicaid Services (CMS) has begun taking feedback on a proposal to cover F-18 sodium fluoride (F-18 NaF) PET imaging studies to identify bone metastasis of cancer under certain conditions.
December 7, 2009
Study recommendations improve injection-to-scan time, PET quantification
By Wayne Forrest
CHICAGO - Researchers at Ohio State University Medical Center have found that injection-to-scan time in FDG-PET is "critically important" for accurately and quantitatively evaluating response to therapy, but optimum target times are complicated by patient and technology challenges.
December 2, 2009
Thinking Systems shows PACS/RIS at RSNA
By AuntMinnie.com staff writers
Thinking Systems is showcasing its upgraded PACS and RIS that have been optimized for multimodality functionality, particularly for molecular imaging.
December 1, 2009
3D software boosts diagnostic accuracy for Alzheimer's
By Wayne Forrest
CHICAGO - 3D stereotactic surface projection (3D-SSP) software enhances the diagnostic accuracy and confidence of both beginner and expert radiologists when interpreting FDG-PET scans of patients with mild cognitive impairment or Alzheimer's disease, according to a study from the Mayo Clinic in Rochester, MN.
November 30, 2009
Bayer initiates phase III trial
By AuntMinnie.com staff writers
Bayer HealthCare Pharmaceuticals has announced enrollment of the first patient in an international phase III open-label, multicenter, nonrandomized, single-dose clinical trial to evaluate the efficacy and safety of its new PET imaging agent.
November 30, 2009
Previous Page
Page 275 of 437
Next Page